The Rare Disease Drug Dilemma: Great Value, High Price, Limited Access?
This webinar will explain how pricing has evolved for the rare disease drug market and best practices for supporting value-based pricing.
Tag: エビデンス＆マーケットアクセス
Effectively Developing Cutting-edge Mobile Tools for Market Access
This webinar explained how to conceptualize, optimize, and kick-off your mobile tool development process.
Certara Evidence & Access Division to Deliver Innovative Thought Leadership at ISPOR Europe
PRINCETON, NJ – Nov 1, 2019 – Certara thought leaders from its Evidence & Access division will present 12 posters at ISPOR Europe.
希少疾患の治療薬を迅速に開発するための革新的なソリューション
This webinar discussed which pharmaceutical payer strategies work and which don’t in our rapidly changing regulatory and reimbursement world.
Certara Expands Evidence & Access Capabilities with Addition of Compass Consulting Team
The strategic expansion of Certara’s US Access practice provides clients with opportunities to confront increasing drug pricing and reimbursement challenges
Certara Announces the Formation of a New Practice Area Focused on Global Health
PRINCETON, NJ – 2019年7月9日 – Certara has formed a new practice area called Certara Global Health (CGH) to focus its technological expertise on helping to achieve equity in health for all people worldwide.
サターラのエビデンス＆アクセスの概要
Advanced Analytics Using RWD Mitigates Risks in AD Drug Development & Reimbursement
This webinar explained how advanced analytics using real-world data can mitigate challenges in Alzheimer’s disease drug approval, reimbursement and utilization.
マーケットアクセス、医療経済・アウトカム研究 (HEOR)、リアルワールド・エビデンスのトレンド
This blog reviews trends for using health economics and outcomes research and real-world evidence to evaluate the value of medicines and health technologies.
医薬品開発での重要性が高まるリアルワールド・エビデンス
The end of 2018 ushered in a flurry of new regulatory guidance and sponsor enthusiasm on real-world evidence (RWE) and its adoption in the drug development process. While the collection of real-world data (RWD) and use of RWE is not new, they are now poised to have a profound impact on our industry. Today, it … Continued
